
Reset all filters
01 1Sandoz Canada Inc.
Reset all filters
01 12623449
Reset all filters
01 1Bivalirudin
Reset all filters
01 1Powder for solution
Reset all filters
01 12028-03-27
Patent Expiration Date : 2028-03-27
Date Granted : 2010-11-02
Brand Name : ANGIOMAX
Patent Number : 2623449
Filing Date : 2008-03-27
Strength per Unit : 250 mg / vial
Dosage Form : Powder for solution
Human Or VET : Human
Route of Administration : Intravenous Injection
Patent Expiration Date : 2028-03-27
Date Granted : 2010-11-02